Herramienta para mejorar la eficiencia en el manejo clínico de pacientes hipertensos

  1. Á. Hidalgo-Vega 1
  2. N. Martell 2
  3. D. Orozco-Beltrán 3
  4. A. Galgo 4
  5. O. Muñiz 5
  6. J.L. Górriz 6
  7. D. Ferrer-Vidal 7
  8. N. Sabaté 8
  9. M. Merino 9
  1. 1 Universidad de Castilla-La Mancha
    info

    Universidad de Castilla-La Mancha

    Ciudad Real, España

    ROR https://ror.org/05r78ng12

  2. 2 Hospital Clínico San Carlos de Madrid
    info

    Hospital Clínico San Carlos de Madrid

    Madrid, España

    ROR https://ror.org/04d0ybj29

  3. 3 Centro de Salud Cabo Huertas, San Juan de Alicante
  4. 4 Centro de Salud Espronceda, Madrid
  5. 5 Hospital Universitario Virgen del Rocío
    info

    Hospital Universitario Virgen del Rocío

    Sevilla, España

    ROR https://ror.org/04vfhnm78

  6. 6 Hospital Clínico Universitario Valencia
  7. 7 Instituto Catalán de Salud
  8. 8 Hospital Universitario Vall dˊHebron
  9. 9 Weber, Economía y Salud, Majadahonda
Revista:
Hipertensión y riesgo vascular

ISSN: 1889-1837

Ano de publicación: 2019

Volume: 36

Número: 2

Páxinas: 70-84

Tipo: Artigo

DOI: 10.1016/J.HIPERT.2018.06.002 PMID: 30037730 SCOPUS: 2-s2.0-85057486865 DIALNET GOOGLE SCHOLAR

Outras publicacións en: Hipertensión y riesgo vascular

Resumo

Objective To create a tool to evaluate the efficiency of the clinical management of hypertensive patients in Primary Care. Material and methods A web-based questionnaire was designed for Primary Care centres to self-evaluate the management of hypertension in five specific areas: information systems, diagnostic and analytical tests, organisational aspects, use of resources, and continuous training programmes for patients and healthcare professionals. A committee of experts previously defined these questions and their ideal responses or “control”, based on the scientific literature or, if there were no published references, by consensus of the committee. A descriptive analysis was performed on the data, and an adherence score was created that ranged from 0 (no adherence) to 1 (total adherence). Results A total of 35 Primary Care centres entered their data into the website for the clinical management of hypertensive patients. The highest adherence to the ideal algorithm was observed in the area “Diagnostic and analytical tests” (0.69 ± 0.10), and the lowest in “Continuous training programmes for patients and professionals” (0.42 ± 0.21). Conclusions The efficiency of clinical management in hypertensive patients can be analysed using the website tool created for this purpose. Its use allows an internal audit to detect the areas that need improvement, and also serves to make comparative evaluations in the different areas of management over time.

Referencias bibliográficas

  • Anchala, R., Pinto, M.P., Shroufi, A., Chowdhury, R., Sanderson, J., Johnson, L., et al. The role of Decision Support System (DSS) in prevention of cardiovascular disease: A systematic review and meta-analysis. PloS One, 7, 2012, e47064.
  • Bérard, E., Bongard, V., Haas, B., Dallongeville, J., Moitry, M., Cottel, D., et al. Score of adherence to 2016 European cardiovascular prevention guidelines predicts cardiovascular and all-cause mortality in the general population. Can J Cardiol 33 (2017), 1298–1304.
  • Carnicero, J., Fernández, A., Manual de salud electrónica para directivos de servicios y sistemas de salud. 1st ed, 2012, Naciones Unidas, Santiago de Chile.
  • Gorostidi, M., Banegas, J.R., de la Sierra, A., Vinyoles, E., Segura, J., Ruilope, L.M., Ambulatory blood pressure monitoring in daily clinical practice – the Spanish ABPM Registry experience. Eur J Clin Invest 46 (2016), 92–98.
  • Lim, S.S., Vos, T., Flaxman, A.D., Danaei, G., Shibuya, K., Adair-Rohani, H., et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2224–2260.
  • Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2095–2128.
  • Mullins, C.D., Sikirica, M., Seneviratne, V., Ahn, J., Akhras, K.S., Comparisons of hypertension-related costs from multinational clinical studies. PharmacoEconomics 22 (2004), 1001–1014.
  • National Institute of Health and Clinical Excellence. Hypertension in adults: Diagnosis and management [consultado 24 Agos 2011]. Disponible en: https://www.nice.org.uk/guidance/cg127; 2011.
  • National Institute of Health and Clinical Excellence. Hypertension: Costing report [consultado 29 Ene 2018]. Disponible en: https://www.nice.org.uk/guidance/cg127/resources/costing-report-pdf-247327309; 2011.
  • Preysler, C., Toledo: el control de la HTA lo abonará el paciente. Correo Farmacéutico, 2017 Oct 17.
  • Puig-Junoy, J., Eficiencia en la atención primaria de salud: Una revisión crítica de las medidas de frontera. Rev Esp Salud Pública 74 (2000), 483–495.
  • Rinfret, S., Lussier, M.T., Peirce, A., Duhamel, F., Cossette, S., Lalonde, L., et al. The Impact of a multidisciplinary information technology–supported program on blood pressure control in primary care. Circ Cardiovasc Qual Outcomes 2 (2009), 170–177.
  • Rodriguez-Roca, G.C., Alonso-Moreno, F.J., Garcia-Jimenez, A., Hidalgo-Vega, A., Llisterri-Caro, J.L., Barrios-Alonso, V., et al. Cost-effectiveness of ambulatory blood pressure monitoring in the follow-up of hypertension. Blood Press 15 (2006), 27–36.
  • Royo-Bordonada, M., Armario, P., Bejarano, J.L., Pedro-Botet, J., Alvarez, F.V., Elosua, R., et al. Adaptación española de las guías europeas de 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica. Hipertens Riesgo Vasc 34 (2017), 24–40.
  • Saez, M., Barceló M.A., Coste de la hipertensión arterial en España. Hipertens Riesgo Vasc 29 (2012), 145–151.
  • Sicras-Mainar, A., Navarro-Artieda, R., Coste de la hipertensión arterial según grados de morbilidad en atención primaria. Med Clín 133 (2009), 290–295.
  • Weltermann, B., Viehmann, A., Kersting, C., Improving management of resistant hypertension: Rationale and protocol for a cluster randomized trial addressing physician managers in primary care. Contemp Clin Trials 47 (2016), 109–114.
  • Woolsey, S., Brown, B., Ralls, B., Friedrichs, M., Stults, B., Diagnosing hypertension in primary care clinics according to current guidelines. J Am Board Fam Med 30 (2017), 170–177.
  • World Health Organization. The world health report 2002: Reducing risks, promoting healthy life [consultado 6 Oct 2017]. Disponible en: https://books.google.com/books?hl=en&lr=&id=epuQi1PtY_cC&oi=fnd&pg=PR9&dq=%22%E2%80%93+Sadag+%E2%80%93%22+%22relevant+than+it+is%22+%22and+diphtheria+by+providing+protection+against+the%22+%22risks+to+health,+the+subject+of+this+year%E2%80%99s+World+health+report,+has+been+a%22+&ots=N3E59ZykQl&sig=iIShKTlWTi_QRySvJtC-C4KP2js; 2002.
  • Yoo, H.J., Park, M.S., Kim, T.N., Yang, S.J., Cho, G.J., Hwang, T.G., et al. A ubiquitous chronic disease care system using cellular phones and the Internet. Diabet Med 26 (2009), 628–635.